How much funding has MIMETAS US, INC raised?

MIMETAS US, INC has raised $1.2M in total funding, most recently a Grant round.

When was MIMETAS US, INC founded?

MIMETAS US, INC was founded in 2016.

Where is MIMETAS US, INC headquartered?

MIMETAS US, INC is headquartered in ROCKVILLE, Maryland, United States.

What industry is MIMETAS US, INC in?

MIMETAS US, INC operates in Biotech, Drug Discovery, Healthcare.

How many employees does MIMETAS US, INC have?

MIMETAS US, INC has 1-10 employees.

MIMETAS US, INC

Q: Who are MIMETAS US, INC's investors?

MIMETAS US, INC's investors include National Institute of Diabetes and Digestive and Kidney Diseases.

The world's most advanced human tissue and disease models

ROCKVILLE, United States · Founded 2016 · $1.2M raised

Biotech

Drug Discovery

Healthcare

Headquarters: ROCKVILLE, Maryland
Employees: 1–10
Founded: 2016
Business Model: B2B

Website: mimetas.com
Total Funding: $1.2M
Last Round: $1.2M GrantJan 2020
Rounds: 1

About

MIMETAS creates advanced human tissue and disease models using organ-on-a-chip technology to enable faster development of safer and more effective therapies. Their OrganoPlate® platform is the world's first mass-produced, quality-controlled organ-on-a-chip system enabling physiologically relevant 3D cell culture without pumps or tubing. Top pharmaceutical companies worldwide use MIMETAS technology to reduce pipeline risks and advance drug programs.

Summary

MIMETAS US, INC is a Biotech company based in ROCKVILLE, United States, founded in 2016. It has raised $1.2M in total across 1 round, most recently a $1.2M Grant round in Jan 2020. Investors include National Institute of Diabetes and Digestive and Kidney Diseases.

LinkedIn X (Twitter)